IncucyteDRC
IncucyteDRC analyzes live-cell imaging data acquired on the Essen Biosciences IncuCyte ZOOM to summarize cell proliferation measurements and compute dose–response metrics for small-molecule inhibitor studies.
Key Features:
- Data summarization workflow: Summarizes raw IncuCyte ZOOM imaging measurements into analyzable formats using R-based algorithms.
- Dose-response curve calculation: Computes dose–response curves to quantify concentration-dependent effects of small-molecule inhibitors.
- EC50 value determination: Calculates EC50 (half-maximal effective concentration) values as pharmacological potency metrics.
- Normalization across conditions: Normalizes proliferation data across cell lines and growth conditions based on doubling time to enable comparability.
- R package implementation: Provides an integrated R-based analytical framework and functions for summarization and pharmacological parameter computation.
Scientific Applications:
- Cell proliferation studies: Quantifies proliferation dynamics from live-cell imaging to assess the effects of small-molecule inhibitors on cell growth.
- Comparative analysis across conditions: Enables comparison of inhibitor responses across different cell lines or growth conditions using doubling-time normalization and dose–response metrics.
Methodology:
Processes IncuCyte ZOOM live-cell imaging data within an R-based analytical framework using algorithms to summarize experimental results and to calculate dose–response curves and EC50 values.
Topics
Details
- License:
- GPL-2.0
- Tool Type:
- command-line tool
- Operating Systems:
- Windows, Mac
- Programming Languages:
- R
- Added:
- 10/31/2018
- Last Updated:
- 12/10/2018
Operations
Publications
Chapman PJ, James DI, Watson AJ, Hopkins GV, Waddell ID, Ogilvie DJ. IncucyteDRC: An R package for the dose response analysis of live cell imaging data. F1000Research. 2016;5:962. doi:10.12688/f1000research.8694.1. PMID:27703665. PMCID:PMC5031130.
Documentation
Links
Issue tracker
https://github.com/chapmandu2/IncucyteDRC/issues